AMERICAN OTOLOGICAL SOCIETY, INC.
The One Hundred Forty-Second Annual Meeting
May 29-30, 2009
JW Marriott Desert Ridge Resort
Phoenix, Arizona
Deadline for submission: Wednesday, October 15, 2008
Click here to download a MS WORD form of these instructions
Abstract Submission Instructions:
*The conflict of interest form must
be completed at the time of submission of the abstract rather than
only if the
abstract is accepted. The
purpose is to be sure that the PAC consider conflict of interest
in the selection of abstracts. The AOS fax number is 352-751-0696.
Please download the 09 AOS conflict of interest form by clicking
here, file the MS Word document, print and fax when ready to submit
abstract
The American Otological Society accepts on-line submission of abstracts
to
www.americanotologicalsociety.org. The electronic version is not
to contain any extraneous formatting instructions.
The AOS Program Advisory Committee will not consider abstracts that
do not contain the required elements.
Abstracts must be structured according to Otology & Neurotology
Guidelines for Authors
General Format:
A concise abstract of not more than 250 words or less is required
for all original clinical and basic science contributions, including
review articles. The AOS Program Advisory Committee for selection
reviews all abstracts anonymously; please do not place any identifying
information in the body of the abstract, such as referral to authorship
or institution. Also, if the research in your paper is supported
by a grant, or special financial arrangement, this must be identified.
These should be organized according to the headings outlined below.
The author(s) must accept sole responsibility for statements in their
submitted abstract.
Choose an appropriate title reflecting the content of the abstract
body. The title will appear in all publications if chosen for presentation.
No changes to abstract will be accepted after October 15. Do not
include the author’s name(s) in the abstract title or body.
List all authors in proper sequence (numbering 1, 2, 3, etc., if
applicable) using first names, middle initials, and last names and
exact degrees. Specify the primary author and the presenter of the
abstract. Please specify a corresponding author to whom all correspondence
about the abstract will be directed.
The AOS Program Advisory Committee will require a completed manuscript
to the Otology & Neurotology Journal two to three weeks before
the scientific meeting so that the Chairperson of the Program Advisory
Committee has an opportunity to review the manuscript for any commercial
bias, conflict of interest, use of commercial names and any other
identifying information that may conflict with the ACCME requirements.
The program committee may revise submitted abstracts to enforce
compliance with the ACCME requirements.
For clinical studies:
Objective: Brief, clear statement of the main goals of the investigation.
Study design: Specify the type of study-randomized, prospective double
blind; retrospective case review; etc.
Setting: Primary care vs. Tertiary referral center; ambulatory vs.
hospital; etc.
Patients: Primary eligibility criteria and key demographic features.
Intervention(s): Diagnostic, therapeutic, and/or rehabilitative.
Main outcome measure(s): The most
essential criterion that addresses the study’s central hypothesis.
Results: Include statistical measures where appropriate.
Conclusions: Include only those directly supported by data generated
from this study.
For basic science reports:
Hypothesis: Brief, clear statement of the main goals of the investigation.
Background: Concise orientation for the reader unfamiliar with this
line of investigation.
Methods: Succinct summary of techniques and materials employed.
Results: Include statistical measures where appropriate.
Conclusions: Include only those directly supported by data generated from
this study. Emphasize clinical
relevance wherever possible.
For reviews and meta-analysis:
Objective: Brief, clear statement of the goals of the review.
Data sources: Specify database, search methodology, languages covered,
and time frame.
Study selection: Criteria used to select articles for detailed review.
Data extraction: Means of assessing quality, validity, and comparability
of extracted data.
Data synthesis: Specify statistical techniques used for data analysis.
Conclusions: Concise statement of primary inferences with any recommendations.
For All Human Studies: Indicate IRB Approval Number
Support/Acknowledgment:
Author Responsibility/Financial Disclosure/Conflict of Interest Form:
All
authors and contributing individuals are responsible for disclosing any
potential conflict of interest. Conflict of interest of an individual has
two components: 1) a financial relationship with a commercial interest
(e.g., pharmaceutical company or medical device manufacturer); and, 2)
the opportunity to influence content of a CME activity relevant to products
and services of that commercial interest in order to comply with the ACCME
requirements. If abstract is accepted, primary authors, presenters and
contributing individuals will be required to sign a financial disclosure
form and conflict of interest form.
The primary author accepts responsibility
to secure conflict of interest/disclosure statements from all co-authors.
All authors must agree to disclose all non-FDA approved use of FDA approved
drugs during the abstract submission process as well as the actual oral
presentation in order to comply with the ACCME requirement.
Copyright Transmittal:
Abstracts are received with the understanding that
they are not under simultaneous consideration by another publication
and that they are original contributions that have not been previously
published.
Accepted abstracts become the permanent property of Otology & Neurotology
and may not be published elsewhere without permission from Otology & Neurotology.
Publication Statement:
The material in this abstract, (Name of Abstract)
has not been submitted for publication, published, or presented previously
at another national or international meeting and is not under consideration
for presentation at another national or international meeting including
another COSM society. The penalty for duplicate presentation/publication
is prohibition of the author from presenting at a COSM society meeting
for a period of three years.
Submitting Author’s Signature
Please read all instructions carefully. Failure to comply with the instructions
could delay the review of or disqualify your abstract submission.
Abstract
Form Information
The abstract form is located on a seperate page. AOL browser will
not work well for this form. It
is highly suggested not to use AOL to submit your abstract. You may
run the risk of not having all important information cross over the
server.
When listing additional authors, please list in numerical
order. This pertains to the following:
1.
Additional Authors Names
2. Additional Authors Addresses
3. Additional Authors Phone
4. Additional Authors fax
When completing your abstract submission form, please print the
completed form before you submit. This will give you a text copy
of your submission.
When ready to proceed, please
download the 2009 AOS Conflict of Interest / Disclosure Statement
Formy
ALL AUTHORS AGREE TO COMPLY WITH POLICIES STATED ABOVE.
Once the disclosure form
has been completed and faxed, please
click here to access the on-line abstract submission form.
** It has come to the attention of the webmaster and administrator, that the abstract submissions form webpage was not accessable to a few members. The occurances happened from the same institution. If this situation should happen, please contact your web administrator to make sure your web source is not protected from out-going email or form submissions. Thank you